Journal of Clinical Oncology Q1 Unclaimed
The Journal of Clinical Oncology serves its readers as the single most credible, authoritative resource for disseminating significant clinical oncology research. In print and in electronic format, JCO strives to publish the highest quality articles dedicated to clinical research. Original Reports remain the focus of JCO, but this scientific communication is enhanced by appropriately selected Editorials, Commentaries, Reviews, and other work that relate to the care of patients with cancer.
Type: Journal
Type of Copyright: CC BY-NC-ND
Languages: English
Open Access Policy: Open Access
Type of publications:
Publication frecuency: -
3166 €
Gold OA-
Green OA- €
Non OAMetrics
10,054
SJR Impact factor525
H Index574
Total Docs (Last Year)2341
Total Docs (3 years)14282
Total Refs26112
Total Cites (3 years)1352
Citable Docs (3 years)19,71
Cites/Doc (2 years)24,88
Ref/DocAims and Scope
Best articles
A phase I safety and pharmacokinetic (PK) study of navitoclax (N) in combination with docetaxel (D) in patients (pts) with solid tumors.
View moreA randomized study comparing chemotherapy alone with chemotherapy followed by radiotherapy in patients with pathologically staged IIIA Hodgkin's disease.
View moreABVD (8 cycles) versus BEACOPP (4 escalated cycles => 4 baseline) in stage III-IV high-risk Hodgkin lymphoma (HL): First results of EORTC 20012 Intergroup randomized phase III clinical trial.
View moreABVD/MOPP and low-dose involved-field radiotherapy in pediatric Hodgkin's disease: the Stanford experience.
View moreAllogeneic marrow transplantation in the treatment of MOPP-resistant Hodgkin's disease.
View moreAllogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease: the 21-year Seattle experience.
View moreAssessment of the Stanford V Regimen and Consolidative Radiotherapy for Bulky and Advanced Hodgkin's Disease: Eastern Cooperative Oncology Group Pilot Study E1492
View moreAssessment of Tumor Size Reduction Improves Outcome Prediction of Positron Emission Tomography/Computed Tomography After Chemotherapy in Advanced-Stage Hodgkin Lymphoma
View moreAutologous bone marrow transplantation for pediatric Hodgkin's disease: a case-matched comparison with adult patients by the European Bone Marrow Transplant Group Lymphoma Registry.
View moreBreast Cancer Screening in Women Previously Treated for Hodgkin's Disease: A Prospective Cohort Study
View moreBrentuximab Vedotin Combined With Donor Lymphocyte Infusions for Early Relapse of Hodgkin Lymphoma After Allogeneic Stem-Cell Transplantation Induces Tumor-Specific Immunity and Sustained Clinical Remission
View moreBrief chemotherapy, Stanford V, and adjuvant radiotherapy for bulky or advanced-stage Hodgkin's disease: a preliminary report.
View moreCantuzumab Mertansine, a Maytansinoid Immunoconjugate Directed to the CanAg Antigen: A Phase I, Pharmacokinetic, and Biologic Correlative Study
View moreCharacteristics and Outcomes of Breast Cancer in Women With and Without a History of Radiation for Hodgkin's Lymphoma: A Multi-Institutional, Matched Cohort Study
View moreClassical Hodgkin's Disease and Follicular Lymphoma Originating From the Same Germinal Center B Cell
View moreClinical stages I and II Hodgkin's disease: a specifically tailored therapy according to prognostic factors.
View moreCombined modality treatment with low-dose radiation and MOPP chemotherapy for children with Hodgkin's disease.
View moreCombined-Modality Therapy Versus Radiotherapy Alone for Treatment of Early-Stage Hodgkin's Disease: Cure Balanced Against Complications
View moreContemporarily Treated Patients With Hodgkin Lymphoma Have Childbearing Potential in Line With Matched Comparators
View moreDoes histology influence outcome in childhood Hodgkin's disease? Results from the United Kingdom Children's Cancer Study Group.
View moreDonor Lymphocyte Infusions Modulate Relapse Risk in Mixed Chimeras and Induce Durable Salvage in Relapsed Patients After T-Cell-Depleted Allogeneic Transplantation for Hodgkin's Lymphoma
View moreDose Intensity of Chemotherapy in Patients With Relapsed Hodgkin's Lymphoma
View moreDose intensity of MOPP chemotherapy and survival in Hodgkin's disease.
View moreDose-response relationship of complementary radiotherapy following four cycles of combination chemotherapy in intermediate-stage Hodgkin's disease.
View more
Comments